Stay updated on VS-6766 and Everolimus Clinical Trial

Sign up to get notified when there's something new on the VS-6766 and Everolimus Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VS-6766 and Everolimus Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The Publications section now references the Guo et al. Lancet Oncology 2020 article as the original publication and removes the Erratum entry; version notes indicate an addition (v3.5.4) and a corresponding deletion (v3.5.3).
    Difference
    0.1%
    Check dated 2026-05-15T23:56:57.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The page metadata revision/version number has been incremented from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T06:31:17.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Added a Lancet Oncology publication citation for the VS-6766 study with an erratum. Removed the old revision note and updated the record to revision v3.5.2 (replacing v3.5.0).
    Difference
    0.1%
    Check dated 2026-04-17T02:49:28.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T06:22:52.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Revision history updated: added 'Revision: v3.4.3' and removed 'Revision: v3.4.2'.
    Difference
    0.0%
    Check dated 2026-03-12T02:27:18.000Z thumbnail image
  9. Check
    113 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, and the earlier government funding/operating-status notices (v3.4.1) were removed.
    Difference
    0.4%
    Check dated 2026-02-11T12:30:53.000Z thumbnail image

Stay in the know with updates to VS-6766 and Everolimus Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VS-6766 and Everolimus Clinical Trial page.